Yongwei Zheng

10PUBLICATIONS
35CO-AUTHORS
AutoimmunityCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)HaematologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 07, 2026
JMJD1C-mediated epigenetic control of autoimmunity and HIT antibody production.

|Nov 22, 2024
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.

Wen Zhu, Yongwei Zheng, Mei Yu

|Sep 05, 2023
MiR-9-1 controls osteoblastic regulation of lymphopoiesis.

Yongguang Zhang, Danfeng Lin, Yongwei Zheng

|Mar 24, 2023
CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells.

Yongwei Zheng, Mei Yu, Yuhong Chen

|Dec 09, 2022
Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis.

Wen Zhu, Yongwei Zheng, Mei Yu

|Jul 01, 2022
Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;Cohesin mutated AML.

Alison E Meyer, Cary Stelloh, Kirthi Pulakanti

Pageof 2

Frequent Collaborators

6 joint publications

Renren Wen

5 joint publications

Wen Zhu

4 joint publications

Demin Wang

2 joint publications

Sridhar Rao